FDA Inspection 1007329 — Janssen Biotech, Inc.
The FDA completed an inspection of Janssen Biotech, Inc. on February 27, 2017 in Malvern, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Malvern, PA (United States)
Additional Details
Sponsor, Contract Research Organization